The number of cases of #Flu and #RSV worldwide is higher than the same period in previous years. RSV #infection cases have reached the highest peak in recent years, causing children's hospitals to be overwhelmed and even some schools to be closed.The three-year health awareness of the #COVID-19 pandemic and the destructive presentation of respiratory disease transmission have made the development of #PCR testing for respiratory diseases have strong certainty, continuity, rapid growth and other vigorous characteristics.
It has been proven that more than 90% of acute #respiratory infections are non-bacterial, most of which are caused by atypical #pathogens. Atypical pathogens have the characteristics of strong infectivity, rapid transmission, short incubation period, rapid onset, and poor immunity after illness, which often lead to high morbidity and mortality, causing a pandemic of the disease. There are many pathogens that cause respiratory infections, such as #viruses, bacteria, mycoplasma, chlamydia, Legionella and other microorganisms. After infection with various respiratory pathogens, the symptoms are similar: pharyngitis, #fever, #cough, chest tightness, chest pain, etc. A pathogen can cause a variety of clinical manifestations, and the same manifestation can be caused by a variety of pathogens. If the test is not performed, some patients may suffer from long-term fever and cough, or even worsen their condition, or abuse #antibiotics for a long time. In addition, routine tests cannot truly assess the cause of infection and cannot #accurately guide treatment.
#WondfoMolecularDepartment has launched a four-in-one #molecular #POCT test for #COVID-19, #influenza A, influenza B, and #Respiratorysyncytialvirus, which helps clinicians to quickly and accurately diagnose and treat the pathogens infected by patients. #PCR multiplex assays provide precise on-site diagnosis of major respiratory infections, such as #SARS-CoV-2, Flu A, Flu B and RSV in 28-38 minutes.With a tiny cartridge for rapid PCR testing, #UCard Dx™ realizes #“SampleInResultOut” one-step testing with rapid results delivered in 38 minutes. The compatible cartridge for U-Card Dx™ adopts #microfluidic control technology and #lyophilized reagent for ensured testing performance.
For more information get in touch with us Wondfo Molecular
Marketing. Contact me via nicky.tian@wondfo.com.cn and mike.zhang@wondfo.com.cn for more details.
#PCR #Multiplex #Respiratory #Flu #RSV #COVID19 #UcardDX #MolecularPOCT